Rituximab for resistant EAA (Hypersensitivity pneumonitis)?

There are two interesing things about this paper, which describes a case of a disease which is supposed to have identifyable causes, but where many of us find patients who appear to be cryptogenic. The patient who was deteriorating despite pulsed methyl prednisolone and IV cyclophosphamide responded to Rituximab. Has anybody else got experience of monoclonals in this disease?

References

$Abstract Available for Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment$	Lota HK, Keir GJ, Hansell DM, Nicholson AG, Maher TM, Wells AU, Renzoni EA, Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment, Thorax, 2013;68:780-781,
	$David Hansell, Royal Brompton Hospital, London, an author of 'Novel use of rituximab in hypersensitivity pneumonitis refractory to conventional treatment'$

Comments

Please sign in or register to add your thoughts.